EGFR and non-small cell lung carcinoma: Together, this study highlights the importance of the negative feedback loop between Ca2+ and CaM and the critical regulatory role of Ca2+/CaM in the FBXL2-mediated EGFR degradation, providing a viable therapeutic strategy for TKI-resistant NSCLC.